GenixPharmaceucticals Corporation (GENX) — Financial Flexibility Index
GenixPharmaceucticals Corporation (GENX) has a Financial Flexibility Index of -0.01x as of April 2026. Free cash flow of CA$-16.30K (operating CF CA$-16.30K minus capex CA$0.00) represents 0% of total liabilities (CA$1.58 Million). Check GENX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GenixPharmaceucticals Corporation Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for GenixPharmaceucticals Corporation across 11 annual periods. For the full cash flow conversion analysis, see GenixPharmaceucticals Corporation (GENX) cash conversion ratio.
Annual Financial Flexibility Index for GenixPharmaceucticals Corporation (2015–2025)
Year-by-year free cash flow to debt coverage for GenixPharmaceucticals Corporation. Explore GenixPharmaceucticals Corporation cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | CA$-124.07K | CA$-124.07K | CA$1.47 Million | ▲ +44.7% |
| 2024 | -0.15x | CA$-187.34K | CA$-187.34K | CA$1.23 Million | ▲ +6.0% |
| 2023 | -0.16x | CA$-220.67K | CA$-220.67K | CA$1.36 Million | ▲ +21.0% |
| 2022 | -0.21x | CA$-216.24K | CA$-219.58K | CA$1.05 Million | ▲ +63.8% |
| 2021 | -0.57x | CA$-428.31K | CA$-428.31K | CA$755.19K | ▼ -42.5% |
| 2020 | -0.40x | CA$-195.03K | CA$-195.03K | CA$489.88K | ▲ +44.0% |
| 2019 | -0.71x | CA$-58.55K | CA$-58.55K | CA$82.41K | ▼ -326.9% |
| 2018 | 0.31x | CA$34.18K | CA$34.18K | CA$109.15K | ▲ +1013.5% |
| 2017 | -0.03x | CA$-9.35K | CA$-9.35K | CA$272.80K | ▲ +98.6% |
| 2016 | -2.43x | CA$-165.07K | CA$-165.07K | CA$68.04K | ▲ +35.8% |
| 2015 | -3.78x | CA$-418.84K | CA$-452.55K | CA$110.78K | — |